HIV Scientific Papers
Assessment of genotypic patterns associated with HIV-1 sensitivity to ibalizumab.
2020
Jullien H, Leonard M, Cash RB, et al.
Poster #27 presented at: European Meeting on HIV & Hepatitis 2020; October 28-30 2020; virtual.
Long-term efficacy, safety, and durability of ibalizumab-based regimens in subgroup of TMB-202 participants [abstract].
2020
Open Forum Infect Dis.
Towner W, DeJesus E, Schrader S, et al.
7(suppl 1):S542–S543. Proceedings of IDWeek, 2020.
Long-term efficacy, safety, and durability of ibalizumab-based regimens in subgroup of TMB-202 participants.
2020
Towner W, DeJesus E, Schrader S, et al.
Poster #1027 presented at: IDWeek; October 21-25, 2020; virtual.
Disease severity impact on long-term virologic response to ibalizumab in expanded access protocol (TMB-311) [abstract].
2020
Open Forum Infect Dis.
Kumar P, Leider J, Slim J, et al.
7(suppl 1):S532. Proceedings of IDWeek, 2020.
Disease severity impact on long-term virologic response to ibalizumab in expanded access protocol (TMB-311).
2020
Kumar P, Leider J, Slim J, et al.
Poster #1008 presented at: IDWeek; October 21-25, 2020; virtual.